LifeScience BioSimilar

Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...

 January 23, 2023 | News

China NMPA Approves Bio-Thera Solutions’ BAT1806, A Biosimilar to Actemra® (Tocilizumab)

Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage biopharmaceutical company, announced that the China National Medical Products Administration (NM...

 January 18, 2023 | News

Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services

Snapdragon specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing state-of-the-art automation techn...

 November 22, 2022 | News

New Cardinal Health research highlights rheumatologists' increasing confidence in biosimilars

The research revealed that rheumatologists are both more familiar with biosimilars and more comfortable prescribing them than they were in 2020, just in ti...

 October 20, 2022 | News

Polpharma Biologics Announces FDA File Acceptance for Review of Natalizumab, First Proposed Biosimilar to Tysabri®

The application is for an intravenous (IV) route of administration, with the same dosing regimen, presentation and indication as the reference medicine, Ty...

 July 26, 2022 | News

Next-generation Diagnostics Paving the Way to Reach Personalized Medicine

New technologies, sequencing methods, novel software algorithms, and multi-omic approaches empower patients to take more active control of their health out...

 June 15, 2022 | News

Biocon Biologics to Acquire Viatris' Biosimilar Assets for Up to US$3.335 Billion in Cash and Equity

Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASD...

 March 03, 2022 | News

Theramex announces an agreement with Enzene Biosciences Limited for the development and commercialisation of Tocilizumab

Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an agreement with Enzene Biosciences Limit...

 December 24, 2021 | News

Prestige BioPharma and Dr. Reddy’s announce partnership to commercialize trastuzumab biosimilar

Prestige BioPharma Ltd. (KRX: 950210) and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, hereafter referred t...

 December 10, 2021 | News

China to Position Taizhou as a famous Chinese Medical City

 It will build a platform for international exchanges and cooperation in the pharmaceutical and general health industries to further gather innovative...

 November 05, 2021 | News

Eisai and FUJI YAKUHIN will provide new treatment options for hyperuricemia and gout in Five ASEAN Countries

Eisai Co., Ltd. and FUJI YAKUHIN CO., LTD. announced today that they have concluded a license agreement concerning dotinurad (generic name), a treatment fo...

 August 31, 2021 | News

Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosumab Biosimilar drug in India

Osteoporosis is a commonly occurring condition associated with advanced age, and is frequently caused by oestrogen decline in post-menopausal women. It can...

 August 29, 2021 | News

Bottmedical enters the market with innovative braces

Bottmedical has developed clear braces made from bio-based polymers, further details of which can be found in an article&...

 July 29, 2021 | News

Cytiva and Pall to expand manufacturing capacity and services across geographies

Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. ...

 July 27, 2021 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in